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httpsWHAT THIS PAPER ADDS
Although delay is a key modiﬁable factor in the treatment of acute mesenteric ischaemia (AMI), few studies
have sought modiﬁable targets to reduce this parameter. This study found that the key factor is the type of
emergency room (ER) the patient ﬁrst encounters. If this ER was non-surgical, the time to surgical operation was
approximately 15 h and mortality 75%, compared with 10 h and 50% mortality if the ﬁrst ER was surgical. This
study illustrates that patient pathway is a potential target for improvement in the treatment of AMI and the
whole pathway needs to be involved and educated.Objectives: Despite modern advances in diagnosis and treatment, acute arterial mesenteric ischaemia (AMI)
remains a high mortality disease. One of the key modiﬁable factors in AMI is the ﬁrst door to operation time,
but the factors attributing to this parameter are largely unknown. The aim of this study was to evaluate the
factors affecting delay, with special focus on the pathways to treatment.
Methods: This was a single academic centre retrospective study. Patients undergoing intervention for AMI
caused by thrombosis or embolism of the superior mesenteric artery between 2006 and 2015 were identiﬁed
from electronic patient records. Patients not eligible for intervention or with chronic, subacute onset, colonic
only, venous, or non-occlusive mesenteric ischaemia were excluded. Patients were divided into two groups
according to the ﬁrst speciality examining the patient (surgical emergency room [SER], surgeon examining the
patient ﬁrst or non-surgical emergency room [non-SER], internist examining the patient ﬁrst). The primary
endpoint was ﬁrst door to operation time and secondary endpoints were length of stay and 90 day mortality.
Results: Eighty-one patients with AMI were included. Fifty patients (62%) died during the ﬁrst 30 days and 53
(65%) within 90 days. Presenting ﬁrst in non-SER (vs. SER) was independently associated with a ﬁrst door to
operation time of over 12 h (OR 3.7 [95% CI 1.3e10.2], median time 15.2 h [IQR 10.9e21.2] vs. 10.1 h [IQR
6.9e18.5], respectively, p ¼ .025). The length of stay was shorter (median 6.5 days [4.0e10.3] vs. 10.8 days
[7.0e22.3], p ¼ .045) and 90 day mortality was lower in the SER group (50.0% vs. 74.5%, p ¼ .025).
Conclusions: The ﬁrst specialty that the patient encounters seems to be crucial for both delayed management
and early survival of AMI. Developing fast/direct pathways to a unit with both gastrointestinal and vascular
surgeons offers the possibility of improving the outcome of AMI.Keywords: Delay, Embolus, Emergency, Revascularisation, Thrombosis
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increases dramatically with age.1e4 AMI has historically
been a disease in which diagnosis is difﬁcult, if not impos-
sible, treatment nearly futile, and mortality very high.5e7
Patients present with a wide variety of symptoms and
only about 1% of acute abdomen cases are caused by AMI,
which makes it difﬁcult to transfer all patients immediately
to the appropriate unit.4 Computed tomography (CT) is
today widely available in emergency rooms (ER), facilitating
identiﬁcation of anatomy consistent with a diagnosis of
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necrotic material to revascularisation of the remaining
bowel.4,9 Minimally invasive revascularisation methods
have emerged from technological development of endo-
vascular treatment options.4,5,10 Introduction of intestinal
“stroke” units with multimodal treatment options have
improved both bowel and life outcomes.11,12 Despite better
results in selected revascularisation series, the total AMI
mortality has remained very high, usually cited at 42e69%.4
In addition to the fact that AMI itself is highly deadly, pa-
tients presenting with AMI are usually elderly with several
comorbidities.4
Much of the effort in the development of treatment
strategies for AMI has recently focused on new endovas-
cular treatments. Delays and pathways to treatment have
gained much less attention, even though long delays are
known to be a major contributory factor for outcome. Pa-
tients are often referred to a vascular centre too late, at the
time of irreversible ischaemia. Potential reasons for long
delays are a low index of suspicion, difﬁculties in diagnosis,
and operation room logistics.13,14 The sensitivity of CT to
identify occlusion of the superior mesenteric artery (SMA)
in the initial radiologist’s report varies between 66% and
86%, and is signiﬁcantly improved if suspicion of AMI is
raised in the referral.15
Although delayed management is a key modiﬁable factor
in the treatment of AMI, few studies have sought
addressable targets to reduce it. The aim of this study was
to analyse the various time delays in the treatment of AMI
and to seek out the factors related to this process. Identi-
fying the key steps in the care pathway may lead to shorter
delays and ultimately better patient outcomes. Speciﬁcally,
the role of the ﬁrst ER where the patient presented was
examined.MATERIALS AND METHODS
This retrospective cohort study was performed in an aca-
demic teaching hospital (Helsinki University Hospital) that
functions as a secondary and tertiary referral centre
covering a population of approximately 1.5 million. Hel-
sinki University Hospital is the only hospital within the area
that treats vascular emergencies, and thus all patients with
AMI within the catchment area are instructed to be
referred there. Open, endovascular, and hybrid revascu-
larisation options are available at all times. Patients who
were treated for AMI in Helsinki University Hospital in
2006e2015 were identiﬁed from electronic patient re-
cords by conducting a search for the International Classi-
ﬁcation of Diseases 10 (ICD-10) code K55 (Vascular
disorders of intestine) or Nomesco Classiﬁcation of Surgi-
cal Procedures (NCSP) codes for procedures on mesenteric
vessels (PCE17, PCF16, PCF17, PCHXX, PCJ17, PCN16,
PCN17, PCP16, PCP17, PCQ16, PCQ17, PCQ99). An
approval to conduct the study was obtained from the
institutional review board.Deﬁnitions
Patients were classiﬁed based on the ER type and specialty
they were ﬁrst presented. Generally, in Nordic countries,
there are two types of ER e surgical ERs have surgeons (or
surgical residents) in the ER seeing the patient ﬁrst. Non-
surgical ERs have internists (or more recently emergency
medicine doctors) seeing the patient ﬁrst, but may consult a
surgeon if deemed necessary.
In this study, surgical emergency room (SER) was deﬁned
as any ER (secondary or tertiary) where the patient was
seen ﬁrst by a surgeon (or surgical resident). Non-surgical
emergency room (non-SER) was deﬁned as an ER where
the patient was seen ﬁrst by a primary care doctor, internal
medicine doctor, or an emergency medicine physician. The
training and experience of the staff in SER and non-SER are
similar (both residents and attendings of respective speci-
alities). SER and non-SER are located in the same premises
in some of the hospitals, whereas in others they are located
in different buildings.
In most hospitals, both primary care ER and secondary
care ER (internal medicine or surgical ER, or both) work at
the same premises, and an appointed triage nurse (by
consulting an on call physician if deemed necessary) decides
to which specialty and level of care the patient is referred
ﬁrst. If the patient presented to an ER with both surgical
and internal medicine ER, the specialty to which the patient
was referred ﬁrst determined whether the patient was
classiﬁed into the SER group or non-SER group. The hospital
to which the patient is initially transported is decided by the
paramedics (by consulting an on call pre-hospital emer-
gency physician if deemed necessary). Patients with acute
abdomen are instructed to be referred to a SER. Vascular
centre refers to Helsinki University Hospital, which is where
all the patients of this study were ﬁnally referred.
Timestamps of ﬁrst ER presentation, CT scan, CT report,
and arrival at vascular centre were extracted from elec-
tronic patient records. Time of diagnosis was the ﬁrst time
hospital notes mentioned AMI as the working diagnosis.
Date of death was obtained from electronic patient records,
which automatically updates the information from the
Population Register Centre, enabling recording of mortality
for all patients.
The Charlson comorbidity index (CCI) was used to assess
comorbidity of patients.16 Quick Sepsis Related Organ Fail-
ure Assessment (qSOFA) was used to evaluate organ
dysfunction at the time of arrival at the vascular centre.17Patients
Patient records were analysed and data regarding patient
characteristics, hospital stay, treatment, and outcome were
extracted manually. Patients with no AMI (incorrect diag-
nosis code), no timestamp available, non-occlusive or
venous ischaemia, bowel ischaemia caused by strangula-
tion, trauma, or isolated coeliac trunk stenosis as well as
ischaemia isolated to the colon were excluded. Because the
Patient search with
ICD-10/NCSP codes
n=474
Bowel ischaemia, not
restricted to colon,
Excluded:
No bowel ischaemia
n=102
Bowel ischaemia of the
colon n=113
Bowel strangulation
n=23
Excluded:
844 Aurora N. Lemma et al.study aim was to analyse delays in the treatment of AMI,
patients whose symptoms started in the hospital during
treatment of another disease, who were not eligible for
interventional treatment because of comorbidity or
advanced age, who had a diagnosed chronic mesenteric
ischaemia as well as patients with subacute onset of
mesenteric ischaemia (deﬁned as delay more than 48 h
from symptom onset to vascular centre) were excluded, in
an effort to limit the study group to patients with an acute
disease.not caused by
strangulation n=236
Final study cohort
n=81
Symptoms started in the
hospital during treatment
of another disease n=52
      
Time of arrival at first
medical center not
available n=10
Diagnosed chronic
mesenteric ischaemia
n=10
Subacute (delay more
than 48 hours from
symptom onset to
vascular center) n=46
Not eligible for operative
treatment n=9
Etiology of AMI other
than SMA embolism or
thrombosis n=28
Figure 1. Flow chart of patient selection. AMI ¼ acute mesenteric
ischaemia; ICD ¼ International Classiﬁcation of Diseases; NCSP ¼
Nordic Classiﬁcation of Surgical Procedures; SMA ¼ superior
mesenteric artery.Statistics
All statistical analyses were done using IBM SPSS Statistics
version 23 (IBM Corp, Armonk, NY, USA). ManneWhitney U
or chi-square tests were used in univariable analyses.
Multivariable analysis was performed using logistic regres-
sion. Variables with p < .2 in univariable analysis were
selected for multivariable analysis, except for variables
which could be expected to cause multicollinearity. The
primary endpoint was ﬁrst door to operation time, which
was deﬁned as the time from arrival at ﬁrst ER to the onset
of surgery. A two tailed p value < .05 was considered to be
statistically signiﬁcant.
RESULTS
Patient characteristics and symptoms
A total of 474 patients were identiﬁed based on the initial
diagnosis and procedure code search. After applying the
exclusion criteria, 81 patients remained for ﬁnal analysis
(Fig. 1). The basic characteristics of the included patients are
shown in Table 1. Brieﬂy, the patients were elderly (median
age 78 years) with an equal sex distribution. The majority
(n ¼ 71, 88%) had some form of cardiovascular disease and
approximately every third patient (n ¼ 29, 36%) had dia-
betes. More than half of the patients (n ¼ 46, 57%) had
atrial ﬁbrillation. Two thirds of all patients were indepen-
dent, and 13 (16%) were residents of a nursing home or an
assisted living facility. Abdominal pain was the most com-
mon symptom (n ¼ 79, 98%), followed by vomiting/nausea
(n ¼ 48, 59%) (Table 2). CT was performed on 18 (22%)
patients in the ﬁrst ER, and 14 (17%) of the CTs were per-
formed with intravenous contrast. CT was performed on 53
(65%) patients at the tertiary vascular centre, and overall 69
(85%) patients underwent CT before intervention. The most
common ﬁrst working diagnosis was unspeciﬁed acute
abdomen (n ¼ 28, 35%) (Table 2). On presentation at the
vascular centre, abdominal guarding was present in 35
(43%) patients (Table 2). The diagnosis of AMI was made
during laparotomy in 10 (12%) patients (Table 2).Factors related to the delay
Factors associated with the delay were analysed in uni-
variable analysis (Table S1). The ﬁrst door to operation time
was signiﬁcantly shorter if the ﬁrst medical centre was a
surgical ER (10.1 h vs. 15.2 h, p ¼ .025), if AMI was correctly
diagnosed in the ﬁrst medical centre (median 9.3 h vs.13.9 h, p ¼ .006), or if SMA occlusion was correctly iden-
tiﬁed in the CT (11.7 h vs. 18.0 h, p ¼ .005) (Table S1).
In multivariable analysis, the ﬁrst medical centre being
SER was independently associated with a shorter ﬁrst door
to operation delay (Table 3).Pathway to treatment
As the ﬁrst ER was the strongest predictor of delay, path-
ways to treatment were examined in more detail. Of 81
patients, 51 presented ﬁrst to non-SER, 14 to SER without
vascular on call, and 16 to SER with vascular on call
(vascular centre). Of the 51 patients presenting ﬁrst to non-
SER, 8 (16%) were referred to SER without vascular on call,
while 43 (84%) patients were referred to SER with vascular
on call. Basic patient characteristics were similar regardless
of whether patients presented to SER or non-SER initially
(Table 1). There were no differences regarding aetiology
(embolism vs. thrombosis), speciﬁc symptoms, or duration
of symptoms between patients arriving ﬁrst at SER or non-
SER (Table 2). CT was more often obtained in the ﬁrst ER if
the patient presented ﬁrst to SER and the ﬁrst working
diagnosis was more often mesenteric ischaemia in SER
(Table 2). The most common incorrect diagnoses in the SER
group were ruptured abdominal aneurysm (n ¼ 6, 20%) and
unspeciﬁed acute abdomen (n ¼ 3, 10%). In the non-SER
group, the most common incorrect diagnoses were non-
Table 1. Basic demographics based on ﬁrst emergency room (surgical or non-surgical) of presentation
All
n [ 81
n (%)
Surgical emergency room (ER)
n [ 30
n (%)
Non-surgical ER
n [ 51
n (%)
p value
Age, median (interquartile range, IQR) in years 78.0 (69.0e85.0) 81.0 (65.3e84.0) 77.0 (70.0e85.0) .51
Sex, female 39 (48.1%) 15 (50.0%) 24 (47.1%) .80
Comorbidities
Hypertension 50 (61.7%) 16 (53.5%) 34 (66.7%) .23
Atrial ﬁbrillation 46 (56.8%) 16 (53.5%) 30 (58.8%) .63
Atherosclerosis 27 (33.3%) 9 (30.0%) 18 (35.3%) .63
Coronary artery disease 33 (40.7%) 12 (40.0%) 21 (41.2%) .92
Cerebrovascular disease (stroke/transient
ischaemic attach [TIA])
15 (18.5%) 4 (13.3%) 11 (21.5%) .63
History of thromboembolism 5 (6.2%) 2 (6.7%) 3 (5.9%) .89
Diabetes .86
with complications 4 (4.9%) 1 (3.3%) 3 (5.9%)
without complications 25 (30.9%) 9 (30.0%) 16 (31.4%)
No cardiovascular diseases 10 (12.3%) 2 (6.7%) 8 (15.7%) .23
Charlson comorbidity index 1.00
0 1 (1.2%) 0 (0%) 1 (2.0%)
1e2 19 (23.5%) 7 (23.4%) 12 (23.6%)
3e4 25 (30.8%) 10 (33.4%) 15 (29.4%)
> 4 36 (44.4%) 13 (43.3%) 23 (45.1%)
American Society of Anaesthesiologists (ASA) physical
status classiﬁcation
.60
IeII 1 (1.2%) 0 (0%) 1 (2.0%)
IIIeIV 49 (60.5%) 17 (56.7%) 32 (62.8%)
V 27 (33.3%) 11 (36.7%) 16 (31.4%)
Medication
Anticoagulanta 20 (24.7%) 5 (16.7%) 15 (29.4%) .15
Antiplateletb 43 (53.1%) 18 (60.0%) 25 (49.0%) .43
Statin 33 (40.7%) 11 (36.7%) 22 (43.1%) .60
Functional status .63
Independent 57 (70.4%) 21 (70.0%) 36 (70.6%)
Partially dependent 11 (13.6%) 3 (10.0%) 8 (15.7%)
Resident of a nursing home or
an assisted living facility
13 (16.0%) 6 (20.0%) 7 (13.7%)
ASA ¼ American Society of Anaesthesiologists physical status classiﬁcation; ER ¼ emergency room; IQR ¼ interquartile range; TIA ¼ transient
ischaemic attack.
a Warfarin, direct oral anticoagulant, low molecular weight heparin.
b Acetylsalicylic acid, dipyridamole, or clopidogrel.
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(n ¼ 4, 8%) (Table 2). In patients with known atheroscle-
rosis (n ¼ 27), AMI was correctly suspected in nine (33%)
patients. In patients with known atrial ﬁbrillation (n ¼ 46),
AMI was correctly suspected in 13 (28%) patients (Table 2).
On arrival at the vascular centre, guarding and qSOFA
scores were similar regardless of whether patients ﬁrst
presented to SER or non-SER (Table 2).Details of the various time delays
The various time delays were compared in more detail
between patients presenting ﬁrst at SER vs. non-SER. Door
to CT, door to diagnosis, and door to operation times were
all shorter in the SER group compared with the non-SER
group (Table 2).Primary operative treatment
Of the 81 patients, four (5%) underwent endovascular
therapy only. Of those undergoing laparotomy (n ¼ 77),extensive and unsalvageable bowel necrosis was found in
14 (18%) patients, and because of poor prognosis these
patients underwent laparotomy only. Of the remaining pa-
tients, 20 (26%) underwent bowel resection only, 15 (19%)
underwent revascularisation without bowel resection, and
28 (36%) underwent revascularisation followed by bowel
resection (Table 4). The abdominal cavity was left open in
nine (12%) patients with plans to undergo a second look
laparotomy. Consultation with a vascular surgeon was
mentioned in 13 of the 20 patient records (65%) who un-
derwent bowel resection only.
There were no signiﬁcant differences in the choice of
operative treatment between the SER and non-SER groups,
including the number of futile laparotomies (Table 4).
Outcomes
Median follow up time was 1.3 weeks (IQR 0.2e59.4),
because of the high mortality. Fifty patients (62%) died
during the ﬁrst 30 days and 53 (65%) during the ﬁrst 90
days. Although there were no signiﬁcant differences in the
Table 2. Symptoms, imaging, clinical presentation and delays based on ﬁrst emergency room (surgical or non-surgical) of
presentation
All
n [ 81
n (%)
Surgical emergency room (ER)
n [ 30
n (%)
Non-surgical ER
n [ 51
n (%)
p value
Symptoms
Abdominal pain 79 (97.5%) 30 (100.0%) 49 (96.1%) .27
Diarrhoea 36 (44.4%) 13 (43.4%) 23 (45.1%) .88
Haematochezia 15 (18.5%) 5 (16.7%) 10 (19.6%) .74
Vomiting/nausea 48 (59.3%) 16 (53.3%) 32 (62.7%) .41
Duration > 24 h 19 (23.5%) 9 (30.0%) 10 (19.6%) .44
Imaging (in ﬁrst ER)
None 37 (45.7%) 3 (10.0%) 34 (66.7%) <.001
Abdominal plain X-ray 14 (17.3%) 3 (10.0%) 11 (21.6%) .18
Computed tomography (any) 18 (22.2%) 13 (43.3%) 5 (9.8%) .001
with intravenous contrast material 14 (17.3%) 10 (33.3%) 4 (7.8%) <.001
without intravenous contrast
material
4 (4.9%) 3 (10.0%) 1 (2.0%) .11
First working diagnosis <.001
Acute mesenteric ischaemia (AMI) 23 (28.4%) 15 (50.0%) 8 (15.7%)
Acute abdomen, not speciﬁed 28 (34.6%) 3 (10.0%) 25 (49.0%)
Intra-abdominal infection 5 (6.2%) 2 (6.7%) 3 (5.9%)
Ileus 4 (4.9%) 1 (3.3%) 3 (5.9%)
Gastrointestinal bleeding 3 (3.7%) 0 (0%) 3 (5.9%)
Gastroenteritis/colitis 5 (6.2%) 1 (3.3%) 4 (7.9%)
Ruptured aortic aneurysm 6 (7.4%) 6 (20.0%) 0 (0%)
Acute coronary syndrome 2 (2.5%) 1 (3.3%) 1 (2.0%)
Decreased general condition 2 (2.5%) 0 (0%) 2 (3.9%)
Othera 3 (3.7%) 1 (3.3%) 2 (3.9%)
Correct working diagnosis in patients
with atherosclerosis, n ¼ 27
9 (33.3%) 6 (66.7%), n ¼ 9 3 (16.7%), n ¼ 18 .05
Correct working diagnosis in patients
with atrial ﬁbrillation, n ¼ 46
13 (28.3%) 7 (43.8%), n ¼ 16 6 (20.0%), n ¼ 30 .17
Clinical presentation at vascular centre
Guarding 35 (43.2%) 9 (30.0%) 26 (51.0%) .07
Quick sepsis related organ failure
assessment (qSOFA)
.49
0 28 (34.6%) 12 (40.0%) 16 (31.4%)
1 37 (45.7%) 14 (46.7%) 23 (45.1%)
2 13 (16.0%) 4 (13.3%) 9 (17.6%)
3 3 (3.7%) 0 (0%) 3 (5.9%)
C reactive protein (CRP), mg/L
(median, interquartile range, IQR)
73 (18e193) 93 (11e195) 71 (18e163) .83
Creatinine, mmol/L (median, IQR) 103 (65e137) 95 (66e153) 105 (64e135) 1.00
Lactate, mmol/L (median, IQR) 2.9 (1.9e5.2) 2.5 (1.8e4.5) 3.1 (1.9e7.5) .22
Imaging at vascular centre
Computed tomography (CT) (any) 53 (65.4%) 17 (56.7%) 36 (70.6%) .20
with intravenous contrast material 32 (39.5%) 5 (16.7%) 20 (39.2%) .94
without intravenous contrast
material
21 (25.9%) 12 (14.8%) 16 (31.4%) .15
Mesenteric ischaemia diagnosis made at
laparotomy
10 (12.3%) 3 (10.0%) 7 (13.7%) .62
Aetiology .20
Embolism 41 (50.6%) 18 (60.0%) 23 (45.1%)
Thrombosis 40 (49.4%) 12 (40.0%) 28 (54.9%)
Time, median (IQR) in hours
Door to CT (n ¼ 79) 5.5 (2.7e10.6) 2.7 (1.8e4.9) 8.4 (4.3e12.1) <.001
Door to surgical ER (n ¼ 51) n/a n/a 3.5 (2.4e7.1) n/a
Door to diagnosis (n ¼ 77) 6.5 (2.8e12.9) 3.1 (0.8e6.8) 10.0 (5.1e15.9) <.001
CT to operation (n ¼ 79) 5.5 (3.4e9.0) 6.0 (3.6e16.5) 5.3 (3.4e8.8) .28
Door to operation (n ¼ 81) 12.6 (9.2e19.7) 10.1 (6.9e18.5) 15.2 (10.9e21.2) .03
AMI ¼ acute mesenteric ischaemia; CRP ¼ C reactive protein; CT ¼ computed tomography; ER ¼ emergency room; IQR ¼ interquartile range;
qSOFA ¼ quick sepsis related organ failure assessment.
a Intra-abdominal infection, perforation.
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Table 3. Multivariable analysis on parameters affecting ﬁrst door to operation time and 90 day mortality
First door to operation
time >12 h OR (95% CI)
90 day mortality OR (95% CI)
First emergency room (ER)
Surgical Reference Reference
Non-surgical 3.7 (1.3e10.2) 3.2 (1.03e9.6)
No antiplatelet medication at presentation 4.8 (1.45e15.9)
Dependent 6.9 (1.63e29.1)
Quick sepsis related organ failure assessment
(qSOFA) > 0 on arrival at vascular centre
4.7 (1.5e14.3)
ER ¼ emergency room; qSOFA ¼ quick sepsis related organ failure assessment; OR ¼ odds ratio; CI ¼ conﬁdence interval.
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shorter hospital stay (median 6.5 days [4.0e10.3] vs. 10.8
days [7.0e22.3], p ¼ .045), as well as lower 90 day mor-
tality (50% vs. 75%) were noted in the SER group compared
with the non-SER group (Table 4). Factors associated with
90 day mortality in univariable and multivariable analyses
were non-SER as the ﬁrst ER (OR 3.2), no antiplatelet
medication on presentation (OR 4.8), patient dependency
(OR 6.9), and qSOFA > 0 on arrival to the vascular centre
(OR 4.7) (Table S2).
DISCUSSION
In this study, the most important prognostic factor for the
patients with AMI was the type of ER at which the patients
were examined ﬁrst. Patients examined ﬁrst at a surgical ER
had shorter ﬁrst door to operation times (10 vs. 15 h),Table 4. Primary intervention and outcomes, based on whether or
All
n [ 81
n (%)
Primary intervention
Endovascular treatment only 4 (4.9%)
Laparotomy, exploration only 14 (17.3%)
Laparotomy, bowel resection only 20 (24.7%)
Laparotomy, vascular procedure only 15 (18.5%)
Embolectomy 13 (16.0%)
Bypass grafting 2 (2.5%)
Endarterectomy 0 (0%)
Endovascular therapy 0 (0%)
Laparotomy, bowel resection and vascular procedure 28 (34.6%)
Embolectomy 14 (17.3%)
Bypass grafting 10 (12.3%)
Endarterectomy 1 (1.2%)
Endovascular therapya 3 (3.7%)
Irreversible bowel ischaemia 62 (76.5%)
Open abdomen 9 (11.1%)
Intensive care unit (ICU) admission 29 (35.8%)
ICU free timeb, median (interquartile range, IQR), in days 5 (1e24)
Length of ICU stay within 28 days, median
(IQR), in days
5.0 (2.8e7.
Length of hospital stay, median (IQR), in days 8.8 (5.9e15
30 day mortality 50 (61.7%)
90 day mortality 53 (65.4%)
ICU ¼ intensive care unit; IQR ¼ interquartile range; ER ¼ emergency ro
a Endovascular therapy was performed via groin puncture prior to laparo
b Time period in which patient was not in ICU and alive within 28 daysshorter hospital stays (7 vs. 11 days), and lower 90 day
mortality rate (50% vs. 75%) compared with those examined
ﬁrst at a non-surgical ER. Although selected in retrospect the
two groups were similar with regard to medical history,
clinical presentation, ﬁnal diagnosis (embolism vs. throm-
bosis), and selected treatment, suggesting that there is an
element of chance that has an effect on the choice of the
initial ER and outcome. Triage nurses and paramedics should
be educated in an attempt to minimise incorrect referrals.
Various studies have stressed the need for more efﬁcient
diagnostic tests and shorter delays in the treatment of
AMI.3,13,18 Previous studies have shown that clinical suspi-
cion and CT imaging are crucial components of delay.13e15
The study by Lehtimäki et al. also found that radiological
detection of AMI on CT is improved if the clinician suspects
the diagnosis.15 The present study found both clinicalnot ﬁrst emergency room was surgical
Surgical emergency room (ER)
n [ 30
n (%)
Non-surgical ER
n [ 51
n (%)
p value
2 (6.7%) 2 (3.9%) .58
3 (10.0%) 11 (21.6%) .18
4 (13.3%) 16 (31.4%) .07
7 (23.3%) 8 (15.7%) .39
5 (16.7%) 8 (15.7%)
2 (6.7%) 0 (0%)
0 (0%) 0 (0%)
0 (0%) 0 (0%)
14 (46.7%) 14 (27.5%) .08
6 (20.0%) 8 (15.7%)
4 (13.3%) 6 (11.8%)
1 (3.3%) 0 (0%)
3 (10.0%) 0 (0%)
21 (70.0%) 41 (80.4%) .29
6 (20.0%) 3 (5.9%) .15
10 (33.3%) 19 (37.3%) .72
12 (1e26) 4 (0e24) .19
3) 5.0 (3.8e6.3) 4.0 (2.0e8.0) .36
.5) 6.5 (4.0e10.3) 10.8 (7.0e22.3) .05
15 (50.0%) 35 (68.6%) .10
15 (50.0%) 38 (74.5%) .02
om.
tomy.
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848 Aurora N. Lemma et al.suspicion and CT imaging to be related to the status of the
ﬁrst medical centre. It is widely recommended that patients
with a suspicion of AMI should be imaged with prompt CT
angiography.3,4,19 However, the present material was too
small to detect a difference between contrast and non-
contrast enhanced CT.
The present mortality rates (51% in the SER group and
72% in the non-SER group) did not differ signiﬁcantly from
previously published mortality ﬁgures of 42e69%.10,20e23
Lower rates of mortality for AMI have been presented24
but the mortality ﬁgures are signiﬁcantly inﬂuenced by a
selection bias, when only revascularised patients are re-
ported. To focus speciﬁcally on AMI and avoid cases with
subacute onset, patients with a prolonged referral (more
than 48 h) and in hospital initiated symptoms were
excluded, a decision that led to a smaller, but more ho-
mogenous patient group with acute and severe AMI. Also
the present material includes speciﬁcally only arterial AMI,
whereas patients with venous mesenteric ischaemia were
excluded as they have a more favourable prognosis and
different delay pattern.25e28
Some studies have shown increasing mortality with
increasing ﬁrst door to operation time,14,29,30 although
this was not detected in the present study. This could be a
result of the heterogeneity of the patient sample despite
efforts to homogenise the cohort. Another reason could
be that patients with more serious symptoms travel
through the system faster. These patients usually have
more severe disease and, hence, higher mortality. Patients
with less severe disease often have less serious symptoms,
thus it may take more time to proceed to operation. These
patients might be able to tolerate longer delays, possibly
because of the extent and anatomy of the obstruction
(partial vs. total, proximal vs. more distal), among others.
This disparity of patients could offer a possible explana-
tion for the lack of correlation between delay and
outcome. A report from Sweden did not ﬁnd any corre-
lation between survival and delay from onset of symptoms
to operation.10 In the present study, efforts were made to
further subgroup occlusions with regards to number of
side branches prior to the occlusion, length of occlusion,
etc., but the number of contrast enhanced CTs remained
too small to draw any conclusions. To achieve fast track
diagnosis and revascularisation, these patients must be
identiﬁed from a large cohort with more or less non-
speciﬁc symptoms. A high level of suspicion and a low
threshold for contrast enhanced CT imaging should be
practiced.19 The fear of acute kidney injury should not
prevent proper diagnostics for this deadly disease, espe-
cially as the nephrotoxicity of contrast media has been
questioned.31 Once the diagnosis is suspected and
conﬁrmed, immediate treatment should be undertaken.
The vascular surgeons choose the method of revascular-
isation and should be capable of performing all forms of
interventions either by themselves or together with
endovascular operators. There is a suggestion in the
literature that endovascular treatment should be fav-
oured, but all comparative studies suffer from selectionbias.4,32 Therefore, the level of evidence is low, and the
choice of treatment must ultimately be made on an in-
dividual basis.
Antiplatelet medication at presentation and patients with
a good functional status had a better outcome, whereas
qSOFA >0 was associated with a higher mortality (Table 4).
Because this is a retrospective analysis, it is not possible to
show clear causation, but it is hypothesised that antiplatelet
medication might inhibit progression of the thrombotic
cascade and thus limit the severity of the event.
A good functional status predicted a better outcome,
which could be because of less comorbidity and hence
lower risks of organ failure. It might also be that more
aggressive treatment was pursued in this patient group.
qSOFA is used as a bedside estimate to identify patients
with suspected infection who would beneﬁt from ICU
treatment. It consists of an evaluation of Glasgow Coma
Scale, respiratory rate, and systolic blood pressure. Deteri-
oration of these values can, in addition to infection, be a
sign of more extensive disturbance of vital functions and
bowel ischaemia, which would explain why a higher qSOFA
was associated with higher mortality.
This study has several limitations. As a retrospective study
there is an inherent risk of information bias and mis-
classiﬁcations. By identifying and excluding clearly different
patient groups (Fig. 1), attempts were made to make the
material more homogenous and to focus on acute and severe
AMI. Despite this, the pattern of the disease remains variable
and limits the conclusions that can be drawn from the ma-
terial. Focusing on arterial AMI made the study groups
smaller and posed challenges to the statistical analysis. On
the other hand, the strength of this study is the population
based study design, which diminishes selection bias.
To improve the outcomes of AMI, the ﬁrst door to
operation times need to be shortened. One of the main
ﬁndings of the present study was that these patients fare
better if they present directly to units with surgical exper-
tise. The awareness of paramedical units and ER personnel
performing triage should be improved. The referral patterns
need to be improved and all suspected AMI patients should
ﬁnd their way without delay to a unit performing revascu-
larisations, either dedicated intestinal “stroke” centres or, as
in the present situation, centralised on call units with pos-
sibilities for multidisciplinary treatment at all times.11,12 The
present results highlight that these units should also take a
role in education and design of the whole treatment chain
starting from ﬁrst responders. Future studies should try to
identify simple clinical combinations of symptoms that
could guide the triage and improve the outcome of AMI
patients.CONCLUSIONS
The ﬁrst specialty that the patient encounters seems to be
crucial for both delayed management and early survival of
AMI. Developing fast/direct pathways to a unit with both
gastrointestinal and vascular surgeons offers the possibility
of improving the outcome of AMI.
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